{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:10:59Z","timestamp":1778789459001,"version":"3.51.4"},"reference-count":46,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.61622\/rbgo\/2026rbgo25","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:56:26Z","timestamp":1778788586000},"source":"Crossref","is-referenced-by-count":0,"title":["Association between High AMH Levels in PCOS Patients and IVF\/ICSI Outcomes: a systematic review and meta-analysis"],"prefix":"10.61622","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1123-2310","authenticated-orcid":false,"given":"Ang\u00e9lica","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-6021","authenticated-orcid":false,"given":"Renato","family":"Ferreira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0018-9264","authenticated-orcid":false,"given":"Ana Margarida","family":"P\u00f3voa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","reference":[{"issue":"1","key":"key20260514195621_B1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119-30.e3. doi: 10.1016\/j.fertnstert.2014.09.041","journal-title":"Fertil Steril"},{"issue":"1","key":"key20260514195621_B2","first-page":"1","article-title":"Antim\u00fcllerian hormone use and misuse in current reproductive medicine practice: a clinically oriented review","volume":"3","author":"Quinn","year":"2022","unstructured":"Quinn M, Cedars MI, Huddleston HG, Santoro N. Antim\u00fcllerian hormone use and misuse in current reproductive medicine practice: a clinically oriented review. F S Rev. 2022;3(1):1-10. doi: 10.1016\/j.xfnr.2021.11.001","journal-title":"F S Rev"},{"issue":"4","key":"key20260514195621_B3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120(4):767-93. doi: 10.1016\/j.fertnstert.2023.07.025","journal-title":"Fertil Steril"},{"issue":"1","key":"key20260514195621_B4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12978-023-01724-7","article-title":"Access to infertility care in Brazil: validation of a questionnaire for a bioethical discussion","volume":"20","author":"Oppenheimer","year":"2023","unstructured":"Oppenheimer D, Caldas CP, Rego F, Nunes R. Access to infertility care in Brazil: validation of a questionnaire for a bioethical discussion. Reprod Health. 2023;20(1):183. doi: 10.1186\/s12978-023-01724-7","journal-title":"Reprod Health"},{"issue":"1","key":"key20260514195621_B5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.rbmo.2021.08.016","article-title":"High serum anti-M\u00fcllerian hormone concentrations have a negative impact on fertilization and embryo development rates","volume":"44","author":"Tsai","year":"2022","unstructured":"Tsai HW, Liao PF, Li CJ, Lin LT, Wen ZH, Tsui KH. High serum anti-M\u00fcllerian hormone concentrations have a negative impact on fertilization and embryo development rates. Reprod BioMed Online. 2022;44(1):171-6. doi: 10.1016\/j.rbmo.2021.08.016","journal-title":"Reprod BioMed Online"},{"issue":"11","key":"key20260514195621_B6","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","unstructured":"Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142(11):4891-9. doi: 10.1210\/endo.142.11.8486","journal-title":"Endocrinology"},{"issue":"1","key":"key20260514195621_B7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1095\/biolreprod64.1.293","article-title":"M\u00fcllerian inhibitory substance induces growth of rat preantral ovarian follicles","volume":"64","author":"McGee","year":"2001","unstructured":"McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ. M\u00fcllerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod. 2001;64(1):293-8. doi: 10.1095\/biolreprod64.1.293","journal-title":"Biol Reprod"},{"issue":"5","key":"key20260514195621_B8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","unstructured":"Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96(5):1246-51.e1. doi: 10.1016\/j.fertnstert.2011.08.015","journal-title":"Fertil Steril"},{"issue":"7","key":"key20260514195621_B9","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.fertnstert.2009.01.125","article-title":"Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome","volume":"93","author":"Mashiach","year":"2010","unstructured":"Mashiach R, Amit A, Hasson J, Amzalzg S, Almog B, Ben-Yosef D, et al. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril. 2010;93(7):2299-302. doi: 10.1016\/j.fertnstert.2009.01.125","journal-title":"Fertil Steril"},{"issue":"9","key":"key20260514195621_B10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668-80. doi: 10.1016\/S2213-8587(22)00281-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"key20260514195621_B11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321-36. doi: 10.1097\/AOG.0000000000002698","journal-title":"Obstet Gynecol"},{"issue":"7","key":"key20260514195621_B12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","article-title":"Anti-m\u00fcllerian hormone in PCOS: a review informing international guidelines","volume":"30","author":"Teede","year":"2019","unstructured":"Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, et al. Anti-m\u00fcllerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab. 2019;30(7):467-78. doi: 10.1016\/j.tem.2019.04.006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"key20260514195621_B13","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","unstructured":"Tal R, Seifer DB, Khanimov M, Malter HE, Grazi RV, Leader B. Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol. 2014;211(1):59.e1-8. doi: 10.1016\/j.ajog.2014.02.026","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"key20260514195621_B14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.rbmo.2010.06.041","article-title":"The association between anti-M\u00fcllerian hormone and IVF pregnancy outcomes is influenced by age","volume":"21","author":"Wang","year":"2010","unstructured":"Wang JG, Douglas NC, Nakhuda GS, Choi JM, Park SJ, Thornton MH, et al. The association between anti-M\u00fcllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod BioMed Online. 2010;21(6):757-61. doi: 10.1016\/j.rbmo.2010.06.041","journal-title":"Reprod BioMed Online"},{"issue":"5","key":"key20260514195621_B15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s13224-021-01582-y","article-title":"The effect of age and AMH level on ART outcomes in patients with reduced ovarian reserve: a retrospective cross-sectional study","volume":"72","author":"Hosseinzadeh","year":"2022","unstructured":"Hosseinzadeh F, Kabodmehri R, Mehrafza M, Mansour-Ghanaei M, Sorouri ZZ, Gashti NG, et al. The effect of age and AMH level on ART outcomes in patients with reduced ovarian reserve: a retrospective cross-sectional study. J Obstet Gynaecol India. 2022;72(5):420-5. doi: 10.1007\/s13224-021-01582-y","journal-title":"J Obstet Gynaecol India"},{"key":"key20260514195621_B16","doi-asserted-by":"crossref","first-page":"673284","DOI":"10.3389\/fendo.2021.673284","article-title":"High serum anti-m\u00fcllerian hormone concentrations are associated with poor pregnancy outcome in Fresh IVF\/ICSI cycle but not cumulative live birth rate in PCOS patients","volume":"12","author":"Guo","year":"2021","unstructured":"Guo Y, Liu S, Hu S, Li F, Jin L. High serum anti-m\u00fcllerian hormone concentrations are associated with poor pregnancy outcome in Fresh IVF\/ICSI cycle but not cumulative live birth rate in PCOS patients. Front Endocrinol (Lausanne). 2021;12:673284. doi: 10.3389\/fendo.2021.673284","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20260514195621_B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","unstructured":"Tal R, Seifer CM, Khanimov M, Seifer DB, Tal O. High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology. Reprod Biol Endocrinol. 2020;18(1):20. doi: 10.1186\/s12958-020-00581-4","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"key20260514195621_B18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum Anti-M\u00fcllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","unstructured":"Xi W, Gong F, Lu G. Correlation of serum Anti-M\u00fcllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients. J Assist Reprod Genet. 2012;29(5):397-402. doi: 10.1007\/s10815-012-9726-x","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"key20260514195621_B19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12884-022-04518-0","article-title":"Association of antim\u00fcllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"22","author":"Liu","year":"2022","unstructured":"Liu S, Hong L, Mo M, Xiao S, Wang X, Fan X, et al. Association of antim\u00fcllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer. BMC Pregnancy Childbirth. 2022;22(1):171. doi: 10.1186\/s12884-022-04518-0","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"key20260514195621_B20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5582\/ddt.2023.01044","article-title":"Higher serum AMH level is associated with better pregnancy outcomes of IVF\/ICSI assisted pregnancy in infertile patients under 35 years old","volume":"17","author":"Ye","year":"2023","unstructured":"Ye F, Du Y, Cao W, Jiang R, Qi Q, Sun H, et al. Higher serum AMH level is associated with better pregnancy outcomes of IVF\/ICSI assisted pregnancy in infertile patients under 35 years old. Drug Discov Ther. 2023;17(4):299-303. doi: 10.5582\/ddt.2023.01044","journal-title":"Drug Discov Ther"},{"key":"key20260514195621_B21","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Hoboken: Wiley-Blackwell; 2019.","edition":"2nd ed"},{"key":"key20260514195621_B22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"key20260514195621_B23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/14767058.2016.1272567","article-title":"Can AMH levels predict the need for increased medication during IVF\/ICSI in PCOS women?","volume":"31","author":"Kamel","year":"2018","unstructured":"Kamel A, Ramadan W, Hussein AM, Dahab S, Elsherbini MM, Lasheen YS, et al. Can AMH levels predict the need for increased medication during IVF\/ICSI in PCOS women? J Matern Fetal Neonatal Med. 2018;31(1):32-8. doi: 10.1080\/14767058.2016.1272567","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"key20260514195621_B24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/jhrs.jhrs_112_22","article-title":"The impact of high circulating anti-m\u00fcllerian hormone on endometrial thickness and outcome of assisted reproductive technology in women with polycystic ovarian syndrome: a cohort study","volume":"15","author":"Mohamed","year":"2022","unstructured":"Mohamed AA, Al-Hussaini TK, Hussein RS, Abdallah KS, Amer SA. The impact of high circulating anti-m\u00fcllerian hormone on endometrial thickness and outcome of assisted reproductive technology in women with polycystic ovarian syndrome: a cohort study. J Hum Reprod Sci. 2022;15(4):370-6. doi: 10.4103\/jhrs.jhrs_112_22","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"key20260514195621_B25","first-page":"223","article-title":"Impact of increasing antim\u00fcllerian hormone level on in vitro fertilization fresh transfer and live birth rate","volume":"3","author":"Acharya","year":"2022","unstructured":"Acharya KS, Harris BS, Weber JM, Truong T, Pieper C, Eaton JL. Impact of increasing antim\u00fcllerian hormone level on in vitro fertilization fresh transfer and live birth rate. F S Rep. 2022;3(3):223-30. doi: 10.1016\/j.xfre.2022.06.005","journal-title":"F S Rep"},{"issue":"6","key":"key20260514195621_B26","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.17582\/journal.pjz\/20210802080820","article-title":"Efficacy of anti-mullerian hormone in predicting the levels of sex hormones and pregnancy outcomes in patients with polycystic ovary syndrome undergoing IVF-ET","volume":"54","author":"Du","year":"2022","unstructured":"Du J, Cao Y. Efficacy of anti-mullerian hormone in predicting the levels of sex hormones and pregnancy outcomes in patients with polycystic ovary syndrome undergoing IVF-ET. Pakistan J Zool. 2022;54(6):2707-14. doi: 10.17582\/journal.pjz\/20210802080820","journal-title":"Pakistan J Zool"},{"issue":"12","key":"key20260514195621_B27","article-title":"High anti-m\u00fcllerian hormone strongly correlates with reproductive outcomes in women undergoing assisted reproduction","volume":"69","author":"Jabarpour","year":"2023","unstructured":"Jabarpour M, Amidi F, Rostami S, Aleyasin A, Aghahosseini M, Khodarahmian M, et al. High anti-m\u00fcllerian hormone strongly correlates with reproductive outcomes in women undergoing assisted reproduction. Clin Lab. 2023;69(12). doi: 10.7754\/Clin.Lab.2023.230524","journal-title":"Clin Lab"},{"issue":"12","key":"key20260514195621_B28","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3390\/biomedicines11123150","article-title":"Elevated anti-m\u00fcllerian hormone as a prognostic factor for poor outcomes of in vitro fertilization in women with polycystic ovary syndrome","volume":"11","author":"Vale-Fernandes","year":"2023","unstructured":"Vale-Fernandes E, Barreiro M, Leal C, Macedo RZ, Tom\u00e9 A, Monteiro MP. Elevated anti-m\u00fcllerian hormone as a prognostic factor for poor outcomes of in vitro fertilization in women with polycystic ovary syndrome. Biomedicines. 2023;11(12):3150. doi: 10.3390\/biomedicines11123150","journal-title":"Biomedicines"},{"key":"key20260514195621_B29","doi-asserted-by":"crossref","first-page":"1123125","DOI":"10.3389\/fendo.2023.1123125","article-title":"High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome","volume":"14","author":"Su","year":"2023","unstructured":"Su N, Zhan J, Xie M, Zhao Y, Huang C, Wang S, et al. High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1123125. doi: 10.3389\/fendo.2023.1123125","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20260514195621_B30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12958-023-01173-8","article-title":"Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?","volume":"21","author":"Huang","year":"2023","unstructured":"Huang H, Gao H, Shi Y, Deng B, He X, Lin J, et al. Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women? Reprod Biol Endocrinol. 2023;21(1):121. doi: 10.1186\/s12958-023-01173-8","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"key20260514195621_B31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.30699\/jogcr.9.4.435","article-title":"Antim\u00fcllerian hormone association with polycystic ovary syndrome and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"9","author":"Jaralla","year":"2024","unstructured":"Jaralla NM, Al- Turaihi AM, Alkawaz U, Mossa HA. Antim\u00fcllerian hormone association with polycystic ovary syndrome and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer. J Obstet Gynecol Cancer Res. 2024;9(4):435-41. doi: 10.30699\/jogcr.9.4.435","journal-title":"J Obstet Gynecol Cancer Res"},{"key":"key20260514195621_B32","author":"National Heart, Lung, and Blood Institute","year":"2021","unstructured":"National Heart, Lung, and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies. 2021 [cited 2025 Jun 11]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools","journal-title":"Quality assessment tool for observational cohort and cross-sectional studies"},{"issue":"1","key":"key20260514195621_B33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JP. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55-61. doi: 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"key20260514195621_B34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi: 10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"key20260514195621_B35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12958-023-01153-y","article-title":"Association between serum AMH levels and IVF\/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"21","author":"Yuwen","year":"2023","unstructured":"Yuwen T, Yang Z, Cai G, Feng G, Liu Q, Fu H. Association between serum AMH levels and IVF\/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):95. doi: 10.1186\/s12958-023-01153-y","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"key20260514195621_B36","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41598-023-28724-8","article-title":"Serum levels of anti-M\u00fcllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study","volume":"13","author":"Hou","year":"2023","unstructured":"Hou Y, Wang L, Li Y, Ai J, Tian L. Serum levels of anti-M\u00fcllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study. Sci Rep. 2023;13(1):2127. doi: 10.1038\/s41598-023-28724-8","journal-title":"Sci Rep"},{"issue":"3","key":"key20260514195621_B37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","article-title":"Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology","volume":"14","author":"Lukaszuk","year":"2014","unstructured":"Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, et al. Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol. 2014;14(3):176-81. doi: 10.1016\/j.repbio.2014.03.004","journal-title":"Reprod Biol"},{"issue":"1","key":"key20260514195621_B38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119-30.e3. doi: 10.1016\/j.fertnstert.2014.09.041","journal-title":"Fertil Steril"},{"issue":"8","key":"key20260514195621_B39","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013;98(8):3332-40. doi: 10.1210\/jc.2013-1393","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20260514195621_B40","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","unstructured":"Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957-62. doi: 10.1210\/jc.2003-030727","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20260514195621_B41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","unstructured":"Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update. 2004;10(2):107-17. doi: 10.1093\/humupd\/dmh010","journal-title":"Hum Reprod Update"},{"issue":"1","key":"key20260514195621_B42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92(1):240-5. doi: 10.1210\/jc.2006-1582","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20260514195621_B43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD. Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139(5):825-33. doi: 10.1530\/rep-09-0415","journal-title":"Reproduction"},{"issue":"3","key":"key20260514195621_B44","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370-85. doi: 10.1093\/humupd\/dmt062","journal-title":"Hum Reprod Update"},{"issue":"2","key":"key20260514195621_B45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijgo.12941","article-title":"Serum anti-M\u00fcllerian hormone is associated with oocyte dysmorphisms and ICSI outcomes","volume":"147","author":"Azizi","year":"2019","unstructured":"Azizi E, Naji M, Nazari L, Salehpour S, Karimi M, Borumandnia N, et al. Serum anti-M\u00fcllerian hormone is associated with oocyte dysmorphisms and ICSI outcomes. Int J Gynaecol Obstet. 2019;147(2):179-86. doi: 10.1002\/ijgo.12941","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"key20260514195621_B46","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1038\/s41598-020-76543-y","article-title":"AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles","volume":"10","author":"Dai","year":"2020","unstructured":"Dai X, Wang Y, Yang H, Gao T, Yu C, Cao F, et al. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles. Sci Rep. 2020;10(1):19750. doi: 10.1038\/s41598-020-76543-y","journal-title":"Sci Rep"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:56:32Z","timestamp":1778788592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/association-between-high-amh-levels-in-pcos-patients-and-ivf-icsi-outcomes-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":46,"alternative-id":["10.61622\/rbgo\/2026rbgo25"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2026rbgo25","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e-rbgo25"}}